probenecid has been researched along with Critical Illness in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "46 ml/h/kg, and the elimination half-life time was 53." | 1.40 | Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration. ( Gattringer, KB; Jäger, W; Kraff, S; Thalhammer, F; Vossen, MG, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vossen, MG | 1 |
| Gattringer, KB | 1 |
| Jäger, W | 1 |
| Kraff, S | 1 |
| Thalhammer, F | 1 |
1 other study available for probenecid and Critical Illness
| Article | Year |
|---|---|
Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration.
Topics: Antiviral Agents; Cidofovir; Critical Illness; Cytosine; Hemofiltration; Humans; Male; Middle Aged; | 2014 |